2,053
Views
15
CrossRef citations to date
0
Altmetric
Articles

Association of capsular types with carbapenem resistance, disease severity, and mortality in Acinetobacter baumannii

, , , , , , , , & ORCID Icon show all
Pages 2094-2104 | Received 18 Jun 2020, Accepted 07 Sep 2020, Published online: 24 Sep 2020

References

  • Gaynes R, Edwards JR. National nosocomial infections surveillance system. Overview of nosocomial infections caused by gram-negative bacilli. Clin Infect Dis. 2005 Sep 15;41(6):848–854. DOI:10.1086/432803. PubMed PMID: 16107985.
  • Joly-Guillou ML. Clinical impact and pathogenicity of Acinetobacter. Clin Microbiol Infect. 2005 Nov;11(11):868–873. DOI:10.1111/j.1469-0691.2005.01227.x. PubMed PMID: 16216100.
  • Jerassy Z, Yinnon AM, Mazouz-Cohen S, et al. Prospective hospital-wide studies of 505 patients with nosocomial bacteraemia in 1997 and 2002. J Hosp Infect. 2006 Feb;62(2):230–236. DOI:10.1016/j.jhin.2005.07.007. PubMed PMID: 16307825.
  • Valencia R, Arroyo LA, Conde M, et al. Nosocomial outbreak of infection with pan-drug-resistant Acinetobacter baumannii in a tertiary care university hospital. Infect Control Hosp Epidemiol. 2009 Mar;30(3):257–263. DOI:10.1086/595977. PubMed PMID: 19199531.
  • Mathlouthi N, El Salabi AA, Ben Jomaa-Jemili M, et al. Early detection of metallo-beta-lactamase NDM-1- and OXA-23 carbapenemase-producing Acinetobacter baumannii in Libyan hospitals. Int J Antimicrob Agents. 2016 Jul;48(1):46–50. DOI:10.1016/j.ijantimicag.2016.03.007. PubMed PMID: 27216382.
  • Shlaes DM, Sahm D, Opiela C, et al. The FDA reboot of antibiotic development. Antimicrob Agents Chemother. 2013 Oct;57(10):4605–4607. DOI:10.1128/AAC.01277-13. PubMed PMID: 23896479; PubMed Central PMCID: PMCPMC3811409.
  • Centers for Disease Control (Taiwan). Annual Report of Nosocomial Infections Surveillance System in Taiwan. Available from: https://www.cdc.gov.tw/english/info.aspx?treeid=00ED75D6C887BB27&nowtreeid=F0131176AA46D5DB&tid=1A8C498AF5F8AF5D
  • Lemos EV, de la Hoz FP, Einarson TR, et al. Carbapenem resistance and mortality in patients with Acinetobacter baumannii infection: systematic review and meta-analysis. Clin Microbiol Infect. 2014 May;20(5):416–423. DOI:10.1111/1469-0691.12363. PubMed PMID: 24131374.
  • Willyard C. The drug-resistant bacteria that pose the greatest health threats. Nature. 2017 Feb 28;543(7643):15. DOI:10.1038/nature.2017.21550nature.2017.21550 [pii]. PubMed PMID: 28252092; eng.
  • Russo TA, Luke NR, Beanan JM, et al. The K1 capsular polysaccharide of Acinetobacter baumannii strain 307-0294 is a major virulence factor. Infect Immun. 2010 Sep;78(9):3993–4000. DOI:10.1128/IAI.00366-10. PubMed PMID: 20643860; PubMed Central PMCID: PMCPMC2937447.
  • Geisinger E, Isberg RR. Antibiotic modulation of capsular exopolysaccharide and virulence in Acinetobacter baumannii. PLoS Pathog. 2015;11(2):e1004691. DOI:10.1371/journal.ppat.1004691. PubMed PMID: 25679516; PubMed Central PMCID: PMCPMC4334535.
  • Tipton KA, Chin CY, Farokhyfar M, et al. Role of capsule in resistance to disinfectants, host antimicrobials, and desiccation in Acinetobacter baumannii. Antimicrob Agents Chemother. 2018 Dec;62(12). DOI:10.1128/AAC.01188-18. PubMed PMID: 30297362; PubMed Central PMCID: PMCPMC6256795.
  • Wang N, Ozer EA, Mandel MJ, et al. Genome-wide identification of Acinetobacter baumannii genes necessary for persistence in the lung. MBio. 2014 Jun 3;5(3):e01163–14. DOI:10.1128/mBio.01163-14. PubMed PMID: 24895306; PubMed Central PMCID: PMCPMC4049102.
  • Russo TA, Beanan JM, Olson R, et al. The K1 capsular polysaccharide from Acinetobacter baumannii is a potential therapeutic target via passive immunization. Infect Immun. 2013 Mar;81(3):915–922. DOI:10.1128/IAI.01184-12. PubMed PMID: 23297385; PubMed Central PMCID: PMCPMC3584894.
  • Pan YJ, Lin TL, Chen YH, et al. Capsular types of Klebsiella pneumoniae revisited by wzc sequencing. PLoS One. 2013;8(12):e80670. DOI:10.1371/journal.pone.0080670. PubMed PMID: 24349011; PubMed Central PMCID: PMCPMC3857182.
  • Pan YJ, Lin TL, Lin YT, et al. Identification of capsular types in carbapenem-resistant Klebsiella pneumoniae strains by wzc sequencing and implications for capsule depolymerase treatment. Antimicrob Agents Chemother. 2015 Feb;59(2):1038–1047. DOI:10.1128/AAC.03560-14. PubMed PMID: 25451047; PubMed Central PMCID: PMCPMC4335867.
  • Meletis G, Chatzopoulou F, Chatzidimitriou D, et al. Whole genome sequencing of NDM-1-producing ST11 Klebsiella pneumoniae isolated in a private laboratory in Greece. Microb Drug Resist. 2019 Jan/Feb;25(1):80–86. DOI:10.1089/mdr.2017.0411. PubMed PMID: 29698126.
  • Bellich B, Ravenscroft N, Rizzo R, et al. Structure of the capsular polysaccharide of the KPC-2-producing Klebsiella pneumoniae strain KK207-2 and assignment of the glycosyltransferases functions. Int J Biol Macromol. 2019 Jun 1;130:536–544. DOI:10.1016/j.ijbiomac.2019.02.128. PubMed PMID: 30802520.
  • Hsieh SY, Tseng CL, Lee YS, et al. Highly efficient classification and identification of human pathogenic bacteria by MALDI-TOF MS. Mol Cell Proteomics. 2008 Feb;7(2):448–456. DOI:10.1074/mcp.M700339-MCP200. PubMed PMID: 18045801.
  • European Committee on Antimicrobial Susceptibility Testing (EUCAST). Breakpoint tables for interpretation of MICs and Zone diameters. Available from: http://wwweucastorg/fileadmin/src/media/PDFs/EUCAST_files/Breakpoint_tables/v_80_Breakpoint_Tablesxls. 2018
  • CLSI. Performance standards for antimicrobial susceptibility testing. 28th ed. CLSI supplement M100. Wayne (PA): Clinical and Laboratory Standards Institute; 2018.
  • Hu D, Liu B, Dijkshoorn L, et al. Diversity in the major polysaccharide antigen of Acinetobacter baumannii assessed by DNA sequencing, and development of a molecular serotyping scheme. PLoS One. 2013;8(7):e70329. DOI:10.1371/journal.pone.0070329. PubMed PMID: 23922982; PubMed Central PMCID: PMCPMC3726653.
  • Kenyon JJ, Hall RM. Variation in the complex carbohydrate biosynthesis loci of Acinetobacter baumannii genomes. PLoS One. 2013;8(4):e62160. DOI:10.1371/journal.pone.0062160. PubMed PMID: 23614028; PubMed Central PMCID: PMCPMC3628348.
  • Knaus WA, Draper EA, Wagner DP, et al. APACHE II: a severity of disease classification system. Crit Care Med. 1985 Oct;13(10):818–829. PubMed PMID: 3928249.
  • Chow JW, Yu VL. Combination antibiotic therapy versus monotherapy for gram-negative bacteraemia: a commentary. Int J Antimicrob Agents. 1999 Jan;11(1):7–12. DOI:10.1016/s0924-8579(98)00060-0. PubMed PMID: 10075272.
  • Garner JS, Jarvis WR, Emori TG, et al. CDC definitions for nosocomial infections, 1988. Am J Infect Control. 1988 Jun;16(3):128–140. DOI:0196-6553(88)90053-3 [pii]. PubMed PMID: 2841893; eng.
  • Chuang YC, Sheng WH, Li SY, et al. Influence of genospecies of Acinetobacter baumannii complex on clinical outcomes of patients with acinetobacter bacteremia. Clin Infect Dis. 2011 Feb 1;52(3):352–360. DOI:10.1093/cid/ciq154. PubMed PMID: 21193494.
  • Lee YT, Kuo SC, Yang SP, et al. Impact of appropriate antimicrobial therapy on mortality associated with Acinetobacter baumannii bacteremia: relation to severity of infection. Clin Infect Dis. 2012 Jul;55(2):209–215. DOI:10.1093/cid/cis385. PubMed PMID: 22495546.
  • Cuthbertson L, Kos V, Whitfield C. ABC transporters involved in export of cell surface glycoconjugates. Microbiol Mol Biol Rev. 2010 Sep;74(3):341–362. DOI:10.1128/MMBR.00009-10. PubMed PMID: 20805402; PubMed Central PMCID: PMCPMC2937517.
  • Whitfield C. Biosynthesis and assembly of capsular polysaccharides in Escherichia coli. Annu Rev Biochem. 2006;75:39–68. DOI:10.1146/annurev.biochem.75.103004.142545. PubMed PMID: 16756484.
  • Whitfield C, Roberts IS. Structure, assembly and regulation of expression of capsules in Escherichia coli. Mol Microbiol. 1999 Mar;31(5):1307–1319. PubMed PMID: 10200953.
  • Wyres KL, Cahill SM, Holt KE, et al. Identification of Acinetobacter baumannii loci for capsular polysaccharide (KL) and lipooligosaccharide outer core (OCL) synthesis in genome assemblies using curated reference databases compatible with Kaptive. Microb Genom. 2020 Mar;6(3):e000339. DOI:10.1099/mgen.0.000339. PubMed PMID: 32118530.
  • Holt K, Kenyon JJ, Hamidian M, et al. Five decades of genome evolution in the globally distributed, extensively antibiotic-resistant Acinetobacter baumannii global clone 1. Microb Genom. 2016 Feb;2(2):e000052. DOI:10.1099/mgen.0.000052. PubMed PMID: 28348844; PubMed Central PMCID: PMCPMC5320584.
  • Schultz MB, Pham Thanh D, Tran Do Hoan N, et al. Repeated local emergence of carbapenem-resistant Acinetobacter baumannii in a single hospital ward. Microb Genom. 2016 Mar;2(3):e000050. DOI:10.1099/mgen.0.000050. PubMed PMID: 28348846; PubMed Central PMCID: PMCPMC5320574.
  • Kwon KT, Oh WS, Song JH, et al. Impact of imipenem resistance on mortality in patients with Acinetobacter bacteraemia. J Antimicrob Chemother. 2007 Mar;59(3):525–530. DOI:10.1093/jac/dkl499. PubMed PMID: 17213265.
  • Lee HY, Chen CL, Wu SR, et al. Risk factors and outcome analysis of Acinetobacter baumannii complex bacteremia in critical patients. Crit Care Med. 2014 May;42(5):1081–1088. DOI:10.1097/CCM.0000000000000125. PubMed PMID: 24394630.
  • Traglia GM, Quinn B, Schramm ST, et al. Serum Albumin and Ca2+ are natural competence inducers in the human pathogen Acinetobacter baumannii. Antimicrob Agents Chemother. 2016 Aug;60(8):4920–4929. DOI:10.1128/AAC.00529-16. PubMed PMID: 27270286; PubMed Central PMCID: PMCPMC4958237.